Bolden Therapeutics

Providence, United States

Bolden Therapeutics is a biotechnology company developing first-in-class therapeutics to treat central nervous system diseases.

Jan 2024

Venture - Series Unknown

Biotechnology Therapeutics

Top Investors

Lifespan Vision Ventures National Institute on Aging Partners Resolute

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Bolden Therapeutics

Who are Bolden Therapeutics's investors?

Bolden Therapeutics's investors include Lifespan Vision Ventures, National Institute on Aging, Partners Resolute.

Where is Bolden Therapeutics headquartered?

Bolden Therapeutics is headquartered in Providence, United States.

What does Bolden Therapeutics do?

Bolden Therapeutics is a biotechnology company developing first-in-class therapeutics to treat central nervous system diseases.

What stage is Bolden Therapeutics at?

Bolden Therapeutics is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 9, 2024.

MLA

"Bolden Therapeutics — Funding & Investors." VCBacked, January 9, 2024, https://www.vcbacked.co/company/bolden-therapeutics. Accessed July 4, 2026.

APA

VCBacked. (2024). Bolden Therapeutics — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/bolden-therapeutics

Wikipedia (cite web)

{{cite web |title=Bolden Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/bolden-therapeutics |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 9, 2024.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Vancouver$599K

Epsilogen

London$16.3M

Advanced Microbiome Interventions

Amsterdam$300K